Arrhythmia management after device removal
نویسندگان
چکیده
منابع مشابه
Arrhythmia management after device removal
Arrhythmic management is needed after removal of cardiac implantable electronic devices (CIEDs). Patients completely dependent on CIEDs need temporary device back-up until new CIEDs are implanted. Various methods are available for device back-up, and the appropriate management varies among patients. The duration from CIED removal to implantation of a new CIED also differs among patients. Tempor...
متن کاملSuccessful management of wound dehiscence after implantation of a subcutaneous implantable cardioverter-defibrillator without device removal
Introduction A subcutaneous implantable cardioverter-defibrillator (S-ICD) is now being used as an alternative to a transvenous implantable cardioverter-defibrillator (TV-ICD). Because the location of the device in the body differs between S-ICD and TV-ICD, ICD-related complications need to be managed in a device-specific manner. Therefore, therapeutic strategies for infected wounds may differ ...
متن کاملArrhythmia Management Devices
383 Implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) have become mainstays of clinical cardiology practice for high-risk patients supported by persuasive clinical trial data. Yet, areas of certainty are offset by considerable uncertainty about the criteria for implantation and for reimbursement. This article reviews selected elements of the clinical trial...
متن کاملArrhythmia Management Devices
1576 Implantable cardioverter defibrillators (ICDs) save lives in patients at risk for sudden death attributable to ventricular arrhythmias, pacemakers (PMs) have been improving symptoms in patients with bradyarrhythmias for decades, and, more recently, cardiac resynchronization devices have improved mortality, morbidity, and quality of life for patients with heart failure. However, these devic...
متن کاملArrhythmia Management Devices
2407 More than 2 decades of research has established the role of cardiac resynchronization therapy (CRT) in medically refractory, mild to severe systolic heart failure (HF) with abnormal QRS duration and morphology. CRT confers a mortality benefit, reduces HF hospitalizations, and improves functional outcome in this population, but not all patients consistently demonstrate a positive CRT respon...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Arrhythmia
سال: 2016
ISSN: 1880-4276
DOI: 10.1016/j.joa.2015.09.004